Accendra Health, Inc. · NYSE
Zacks Investment Research
New Strong Sell Stocks for October 9thZacks has added three stocks to its Strong Sell list: Accendra Health (ACH), Ardelyx (ARDX), and Draganfly (DPRO). All three companies have experienced significant downward revisions to their earnings estimates over the past 60 days, with ACH seeing a 109.4% downward revision, ARDX a 25% revision, and DPRO a 59.6% revision.
Zacks Investment Research
New Strong Sell Stocks for October 6thThree companies have been added to the Zacks Rank #5 (Strong Sell) list today due to downward revisions in earnings estimates. AB Volvo faces a 2.3% downward earnings revision, Accendra Health has experienced a significant 109.4% downward revision, and Cameco Corporation saw a 12.2% downward revision over the last 60 days.
Headlines link to the publisher. Not investment advice.
Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
No sentiment yet
Sign in to post on $ACH
No threads yet
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.
